How will payers manage reimbursement of multiple interchangeable biosimilars?

MAC reimbursement
% (1 votes)
Generic non-MAC reimbursement rate
% (1 votes)
Brand reimbursement rate
% (4 votes)
Specialty drug specific rate
% (4 votes)
Average Sales Price (ASP)
% (0 votes)
Average Manufacturer Price (AMP)
% (0 votes)
National Average Drug Acquisition Cost (NADAC)
% (0 votes)
Brand reimbursement rate
40% (4 votes)
Specialty drug specific rate
40% (4 votes)
MAC reimbursement
10% (1 votes)
Generic non-MAC reimbursement rate
10% (1 votes)
Average Sales Price (ASP)
0% (0 votes)
Average Manufacturer Price (AMP)
0% (0 votes)
National Average Drug Acquisition Cost (NADAC)
0% (0 votes)
Back to poll
10 votes
Powered by StrawPoll